Temperature-restricted mutants of human adenovirus type 5. In: strategy of the viral genome.
D000256:Adenoviridae / Q000254:growth & development*; D000818:Animals; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002471:Cell Transformation, Neoplastic / Q000382:microbiology; D002478:Cells, Cultured; D003433:Crosses, Genetic; D004279:DNA, Viral / Q000302:isolation & purification; D005816:Genetic Complementation Test; D006367:HeLa Cells; D006801:Humans; D006898:Hydroxylamines / Q000494:pharmacology; D009153:Mutagens / Q000494:pharmacology; D009154:Mutation / Q000187:drug effects; D009573:Nitrites / Q000494:pharmacology; D010455:Peptides / Q000302:isolation & purification; D051381:Rats; D011995:Recombination, Genetic; D013696:Temperature; D014764:Viral Proteins / Q000302:isolation & purification; D014776:Virus Cultivation